References
- The Polaris Observatory HCV Collaborators. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study. Lancet Gastroenterol Hepatol. 2017;2(3):161–176. doi: 10.1016/S2468-1253(16)30181-9.
- World Health Organization. WHO global hepatitis report 2017; 2017 [cited 2020 Mar 2]. Available from: http://www.who.int/hepatitis/publications/global-hepatitis-report2017/en/
- Gower E, Estes C, Blach S, et al. Global epidemiology and genotype distribution of the hepatitis C virus infection. J Hepatol. 2014;61(1 Suppl.):S45–S57. doi: 10.1016/j.jhep.2014.07.027.
- CDA Foundation. Polaris observatory; 2019 [cited 2020 Mar 2]. Available from: http://cdafound.org/polaris/
- Rao HY, Duan ZP, Wang GQ, et al. Key update points of the guidelines for prevention and treatment of hepatitis C (2019 edition). Zhonghua Gan Zang Bing Za Zhi. 2020;28(2):129–132. doi: 10.3760/cma.j.issn.1007-3418.2020.02.005.
- Health and Family Planning Commission of the People’s Republic of China. Hepatitis C virus screening and management. Beijing: Health and Family Planning Commission of the People’s Republic of China; 2014.
- China United Liver Health Promotion Center, Hepatology Society of Chinese Medical Association, Laboratory Medicine Society of Chinese Medical Association, et al. Management process of hepatitis C in-hospital screening in China (trial). Chin J Clin Hepatol. 2021;37(7):1534–1539. doi: 10.3969/j.issn.1001-5256.2021.07.011.
- Hu LP. How to correctly use the Z-test – two rate comparison general difference Z-test and SAS realization. Si Chuan Jing Shen Wei Sheng. 2020;33(5):431–435.
- WHO. Regional action plan for viral hepatitis 2016–2020. Geneva: World Health Organization; 2015.
- WHO. Up to 10 million people in China could die from chronic hepatitis by 2030—urgent action needed to bring an end to the ‘silent epidemic’ [EB/OL]; 2019 [updated 2016 Jul 26; cited 2020 Sep 03]. Available from: https://www.who.int/china/news/detail/26-07-2016-up-to-10-million-people-in-china-could-die-from-chronic-hepatitis-by-2030-urgent-action-needed-to-bring-an-end-to-the-silent-epidemic-
- Lazarus JV, Wiktor S, Colombo M, et al. Micro-elimination – a path to global elimination of hepatitis C. J Hepatol. 2017;67(4):665–666. doi: 10.1016/j.jhep.2017.06.033.
- Feng B, Zhang J, Wei L. Inadequate awareness of hepatitis C among nonspecialist physicians in China. Adv Med Educ Pract. 2011;2:209–214. doi: 10.2147/AMEP.S23887.
- Ren TQ, Li LM, Yang QQ, et al. Economic analysis and strategy of hepatitis C screening. Chin J Clin Hepatol. 2020;36(10):2305–2309. doi: 10.3969/j.issn.1001-5256.2020.10.032.
- WHO. Global health sector strategy on viral hepatitis 2016–2021. Geneva: World Health Organization; 2016. Available from: https://www.who.int/hepatitis/strategy 2016 -2021/ghss-hep/en/